NASDAQ:ASPI ASP Isotopes (ASPI) Stock Price, News & Analysis $2.19 -0.17 (-7.19%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$2.11▼$2.4050-Day Range$2.03▼$3.8352-Week Range$0.84▼$5.67Volume591,150 shsAverage Volume804,399 shsMarket Capitalization$113.62 millionP/E RatioN/ADividend YieldN/APrice Target$4.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get ASP Isotopes alerts: Email Address ASP Isotopes MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside105.0% Upside$4.50 Price TargetShort InterestBearish17.62% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingAcquiring Shares$423,787 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.24) to ($0.08) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.37 out of 5 starsBasic Materials Sector155th out of 180 stocksMiscellaneous Chemical Products Industry6th out of 7 stocks 3.5 Analyst's Opinion Consensus RatingASP Isotopes has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageASP Isotopes has only been the subject of 1 research reports in the past 90 days.Read more about ASP Isotopes' stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted17.62% of the float of ASP Isotopes has been sold short.Short Interest Ratio / Days to CoverASP Isotopes has a short interest ratio ("days to cover") of 6.6.Change versus previous monthShort interest in ASP Isotopes has recently increased by 8.62%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldASP Isotopes does not currently pay a dividend.Dividend GrowthASP Isotopes does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ASPI. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for ASP Isotopes this week, compared to 1 article on an average week.Search InterestOnly 2 people have searched for ASPI on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat FollowsOnly 5 people have added ASP Isotopes to their MarketBeat watchlist in the last 30 days. This is a decrease of -38% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ASP Isotopes insiders have bought more of their company's stock than they have sold. Specifically, they have bought $423,787.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders26.30% of the stock of ASP Isotopes is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 16.80% of the stock of ASP Isotopes is held by institutions.Read more about ASP Isotopes' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for ASP Isotopes are expected to grow in the coming year, from ($0.24) to ($0.08) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of ASP Isotopes is -4.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of ASP Isotopes is -4.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioASP Isotopes has a P/B Ratio of 9.98. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about ASP Isotopes' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm Press Fmr CIA Advisor reveals PEACEMAKER superweaponKamala cannot get the “codes” to this superweapon. In Trump’s hands, it will restore America’s global dominance. It could also help Americans struggling under Bidenomics by potentially sending 5 military stocks SOARING. Historically, similar stocks have shot up 16,270% in just 18 months.Full details are in this announcement. About ASP Isotopes Stock (NASDAQ:ASPI)ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.Read More ASPI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ASPI Stock News HeadlinesSeptember 3, 2024 | finance.yahoo.comASP Isotopes Inc. Completes Construction Phase of Ytterbium-176 Enrichment FacilityAugust 11, 2024 | finance.yahoo.comSeveral Insiders Invested In ASP Isotopes Flagging Positive NewsSeptember 7, 2024 | Behind the Markets (Ad)The $15 "Insider Secret" That Could Save Your RetirementWhat if I told you there's a $15 stock that a billionaire insider just poured $47 MILLION into? That's right. You can grab shares of this potential retirement-maker for less than you'd pay for lunch.August 7, 2024 | markets.businessinsider.comBuy Rating Justified by ASP Isotopes’ Strategic Expansion and Growing Demand for High-Tech Isotope ProductsJuly 19, 2024 | finance.yahoo.comASP Isotopes Inc. (ASPI)July 18, 2024 | investorplace.com3 Stocks You Haven't Heard of That Could Be the Next Big ThingJuly 15, 2024 | globenewswire.comASP Isotopes Announces Closing of Public Offering and Full Exercise of Underwriter's Option to Purchase Additional SharesJuly 12, 2024 | investorplace.com3 Micro-Cap Stocks Destined for Future Blue-Chip StatusSeptember 7, 2024 | Behind the Markets (Ad)The $15 "Insider Secret" That Could Save Your RetirementWhat if I told you there's a $15 stock that a billionaire insider just poured $47 MILLION into? That's right. You can grab shares of this potential retirement-maker for less than you'd pay for lunch.July 12, 2024 | investorplace.com3 Micro-Cap Stocks Destined for Future Blue-Chip StatusJuly 12, 2024 | investorplace.comWhy Is ASP Isotopes (ASPI) Stock Down 19% Today?July 12, 2024 | globenewswire.comASP Isotopes Announces Pricing of Public Offering of Common StockJuly 11, 2024 | globenewswire.comASP Isotopes Announces Proposed Public Offering of Common StockJune 13, 2024 | globenewswire.comASP Isotopes Inc. Enhances Executive Leadership Team with the Appointment of Heather Kiessling as Chief Financial OfficerMay 24, 2024 | finanznachrichten.deASP Isotopes and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TVMay 24, 2024 | finance.yahoo.comASP Isotopes and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVMay 16, 2024 | investorplace.comASPI Stock Earnings: ASP Isotopes Reported Results for Q1 2024April 17, 2024 | markets.businessinsider.comOptimistic Future for ASP Isotopes: Buy Rating with Increased Price Target Amidst Production and Strategic GrowthSee More Headlines Receive ASPI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ASP Isotopes and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/19/2024Today9/07/2024Next Earnings (Estimated)11/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBasic Materials Industry Miscellaneous chemical products Sub-IndustryChemicals Current SymbolNASDAQ:ASPI CUSIPN/A CIK1921865 Webwww.aspisotopes.com Phone561-709-3034FaxN/AEmployees76Year FoundedN/APrice Target and Rating Average Stock Price Target$4.50 High Stock Price Target$4.50 Low Stock Price Target$4.50 Potential Upside/Downside+105.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.53) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,290,000.00 Net MarginsN/A Pretax Margin-1,057.91% Return on Equity-174.89% Return on Assets-68.75% Debt Debt-to-Equity Ratio2.06 Current Ratio4.00 Quick Ratio4.00 Sales & Book Value Annual Sales$2.30 million Price / Sales49.49 Cash FlowN/A Price / Cash FlowN/A Book Value$0.22 per share Price / Book9.98Miscellaneous Outstanding Shares51,763,000Free Float38,149,000Market Cap$113.62 million OptionableNot Optionable Beta5.11 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Paul Elliot Mann (Age 47)President, CEO & Executive Chairman Comp: $480kMr. Robert Ainscow (Age 47)CFO & COO Comp: $160kDr. Hendrik Strydom B. Sc (Age 63)M. Sc, Ph.D., CTO & Director Comp: $122.4kKey CompetitorsLuxferNYSE:LXFRARQNASDAQ:ARQOrigin MaterialsNASDAQ:ORGNStandard LithiumNYSE:SLIVerde Clean FuelsNASDAQ:VGASView All CompetitorsInsiders & InstitutionsMarshall Wace LLPBought 433,734 shares on 8/14/2024Ownership: 1.053%Rathbones Group PLCBought 42,243 shares on 8/9/2024Ownership: 0.378%Renaissance Technologies LLCBought 9,200 shares on 8/9/2024Ownership: 0.332%Rhumbline AdvisersBought 38,056 shares on 8/1/2024Ownership: 0.058%Fielder Capital Group LLCBought 18,055 shares on 8/1/2024Ownership: 0.027%View All Insider TransactionsView All Institutional Transactions ASPI Stock Analysis - Frequently Asked Questions How have ASPI shares performed this year? ASP Isotopes' stock was trading at $1.79 at the beginning of 2024. Since then, ASPI stock has increased by 22.6% and is now trading at $2.1950. View the best growth stocks for 2024 here. How were ASP Isotopes' earnings last quarter? ASP Isotopes Inc. (NASDAQ:ASPI) posted its quarterly earnings data on Monday, August, 19th. The company reported ($0.24) earnings per share (EPS) for the quarter. The company earned $1.02 million during the quarter. When did ASP Isotopes IPO? ASP Isotopes (ASPI) raised $5 million in an initial public offering on Thursday, November 10th 2022. The company issued 1,300,000 shares at a price of $4.00 per share. Revere Securities acted as the underwriter for the IPO. Who are ASP Isotopes' major shareholders? ASP Isotopes' top institutional shareholders include Marshall Wace LLP (1.05%), Rathbones Group PLC (0.38%), Renaissance Technologies LLC (0.33%) and Bank of New York Mellon Corp (0.19%). Insiders that own company stock include Ak Jensen Investment Managemen, Robert John Andrew Ryan and Duncan Moore. View institutional ownership trends. How do I buy shares of ASP Isotopes? Shares of ASPI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ASPI) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ASP Isotopes Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ASP Isotopes With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.